<p>多年來，DocuSign Inc NASDAQ: DOCU 一直是市場上最受歡迎的失望之一。曾經在疫情期間備受青睞的它，在過去幾年中大部分時間都陷入了一個似乎無盡的錯失機會和投資者熱情減退的循環中。它還發現自己在人工智能革命的錯誤一方，導致其股票在今年早些時候下跌超過 40%。</p>
<p>然而，最近幾周情況開始發生變化。在週四晚上的財報發佈之前，自 5 月中旬以來，股價上漲了大約 30%，投資者對 DocuSign 能夠實現類似 HubSpot Inc NYSE: HUBS 的轉型感到興奮。</p>
<p>然後是週四的報告。儘管公司超出預期並提高了前瞻性指引，但股票卻大幅下跌，分析師們並不滿意。乍一看，這種反應似乎是合理的，但深入分析後，可以認為市場關注的焦點是錯誤的。</p>
<h2>本季度表現好於市場反應所暗示的</h2>
<p>DocuSign 的主要數據再次表現出色，輕鬆超出預期，展現出越來越令人印象深刻的一致性。對於一家試圖説服市場其能夠實現持續復甦的公司來説，這正是你希望圍繞季度報告構建的業績記錄。此外，管理層提高了收入展望，而盈利能力和自由現金流也都令人印象深刻。</p>
<p>除此之外，管理層指出對 DocuSign 的 AI 原生智能協議管理（IAM）平台的需求不斷增長，超過 40,000 個客户已經投資於該產品。對於一家在過去幾年中努力説服投資者其在電子簽名之外有可信增長故事的公司來説，這是一個重要的發展。這也與我們看到的傳統軟件公司試圖與 AI 合作而不是對抗的更廣泛趨勢相契合。</p>
<h2>但逆風依然存在</h2>
<p>然而，問題在於投資者和分析師不僅在尋找更引人注目的東西，還發現了原本樂觀展望中的一些薄弱環節。</p>
<p>例如，DocuSign 的年度經常性收入指引保持不變，增長率為 8.5%，許多人認為這是進入報告前最重要的指標。此外，市場對公司 IAM 增長軌跡的可見性仍然有限。這些原因足以讓美國銀行維持其表現不佳的評級。</p>
<p>摩根士丹利也採取了類似的謹慎態度。儘管承認執行力強和 IAM 採用率上升，但它認為該平台的經濟性仍然難以評估。儘管如此，它維持了對該股票的平等權重評級，其目標價為 69 美元，表明市場的反應過於負面。DocuSign 的股票在週五交易開始時約為 50 美元，這意味着看空的摩根士丹利目標價大約有 40% 的上漲空間。</p>
<h2>華爾街希望在故事完全展開之前看到證據</h2>
<p>看漲的論點很強。願意傾向於樂觀論點的人認為 DocuSign 是一家成功將自己從單一產品提供商轉型為更廣泛的協議管理平台的公司。他們看到客户採用率的增加、產品範圍的擴大，以及 AI 驅動的工作流程創造全新貨幣化機會的潛力。</p>
<p>重要的是，管理層依然充滿信心，並在最近幾個月以創紀錄的水平回購股票。這些通常不是你會期望在經歷生存危機的公司身上看到的事情。</p>
<p>市場的挑戰在於，這些好處尚未完全體現在預期的增長率中，令投資者感到沮喪。在一個許多股票因接近垂直的增長率而迅速上漲的市場中，選擇投資 DocuSign 的機會成本相當高。</p>
<h2>為什麼拋售可能是一個機會</h2>
<p>儘管如此，現在看漲的理由比看跌的理由更多，尤其是考慮到股票的拋售幅度。公司超出預期，提高了前瞻性指引，回購了自己的股票，並在其 AI 舉措中交出了令人鼓舞的結果。</p>
<h3>Docusign Inc. (DOCU) 2026 年 6 月 8 日的價格圖表</h3>
<p>儘管它可能沒有以投資者期望的速度，或與其他軟件股票相似的速度進行所有這些操作，但它仍然保持着穩健的向前勢頭。在這種背景下，DocuSign 的股票仍然接近多年來的低點，這意味着當前的風險回報特徵特別有吸引力。</p>
<h2>你現在應該投資 1000 美元在 Docusign 嗎？</h2>
<p>在考慮 Docusign 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Docusign 並不在名單上。</p>
<p>雖然 Docusign 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

DOCU

<p>儘管 DocuSign (DOCU) 超過了盈利預期並提高了指引，但其股價仍然下跌，這主要是由於年度經常性收入增長預測未變以及對其人工智能平台經濟狀況的可見性有限。儘管像美國銀行這樣的分析師保持謹慎，但該公司在 IAM 採用方面表現出強勁的執行力，並創下了股票回購的新紀錄。該股交易接近多年低點，為押注其超越電子簽名轉型的投資者提供了一個潛在吸引人的風險回報配置</p>

<p>For years, DocuSign Inc NASDAQ: DOCU has been one of the market's favorite disappointments. What was once a pandemic-era darling has spent much of the last few years trapped in a seemingly endless cycle of missed opportunities and fading investor enthusiasm. It’s also found itself on the wrong side of the AI revolution, which sent its stock down by more than 40% earlier this year.</p>
<div class="lb-trans"><p>多年來，DocuSign Inc NASDAQ: DOCU 一直是市場上最受歡迎的失望之一。曾經在疫情期間備受青睞的它，在過去幾年中大部分時間都陷入了一個似乎無盡的錯失機會和投資者熱情減退的循環中。它還發現自己在人工智能革命的錯誤一方，導致其股票在今年早些時候下跌超過 40%。</p>
</div><p>Yet something had started to change in recent weeks. Before Thursday night’s earnings release, shares had rallied roughly 30% since the middle of May as investors grew excited about the potential for DocuSign to pull off a HubSpot Inc NYSE: HUBS style pivot.</p>
<div class="lb-trans"><p>然而，最近幾周情況開始發生變化。在週四晚上的財報發佈之前，自 5 月中旬以來，股價上漲了大約 30%，投資者對 DocuSign 能夠實現類似 HubSpot Inc NYSE: HUBS 的轉型感到興奮。</p>
</div><p>Then came Thursday's report. Despite the company beating expectations and raising forward guidance, the stock sold off sharply, and analysts weren’t impressed. At first glance, this reaction looks justified, but dig a little deeper, and there’s an argument that the market is focusing on the wrong things.</p>
<div class="lb-trans"><p>然後是週四的報告。儘管公司超出預期並提高了前瞻性指引，但股票卻大幅下跌，分析師們並不滿意。乍一看，這種反應似乎是合理的，但深入分析後，可以認為市場關注的焦點是錯誤的。</p>
</div><h2>The Quarter Was Better Than the Market Reaction Suggests</h2>
<div class="lb-trans"><h2>本季度表現好於市場反應所暗示的</h2>
</div><p>With what is becoming impressive consistency, DocuSign’s headline numbers were once again solid and comfortably beat expectations. For a company trying to convince the market it’s capable of making a sustained comeback, that’s exactly the kind of track record you want to be framing quarterly reports around. In addition, management increased its revenue outlook, while profitability and free cash flow were both impressive.</p>
<div class="lb-trans"><p>DocuSign 的主要數據再次表現出色，輕鬆超出預期，展現出越來越令人印象深刻的一致性。對於一家試圖説服市場其能夠實現持續復甦的公司來説，這正是你希望圍繞季度報告構建的業績記錄。此外，管理層提高了收入展望，而盈利能力和自由現金流也都令人印象深刻。</p>
</div><p>Beyond that, executives pointed to growing demand for DocuSign's AI-native Intelligent Agreement Management, or IAM, platform, noting that more than 40,000 customers have now invested in the offering. For a company that spent much of the last several years struggling to convince investors it had a credible growth story beyond electronic signatures, that’s a meaningful development. It also ties in well with the broader trend we’re seeing with traditional software companies trying to work with AI, rather than against it.</p>
<div class="lb-trans"><p>除此之外，管理層指出對 DocuSign 的 AI 原生智能協議管理（IAM）平台的需求不斷增長，超過 40,000 個客户已經投資於該產品。對於一家在過去幾年中努力説服投資者其在電子簽名之外有可信增長故事的公司來説，這是一個重要的發展。這也與我們看到的傳統軟件公司試圖與 AI 合作而不是對抗的更廣泛趨勢相契合。</p>
</div><h2>But the Headwinds Are Still There</h2>
<div class="lb-trans"><h2>但逆風依然存在</h2>
</div><p>However, the problem is that investors and analysts were not only looking for something much more eye-catching, but also saw some weak spots in the otherwise rosy outlook.</p>
<div class="lb-trans"><p>然而，問題在於投資者和分析師不僅在尋找更引人注目的東西，還發現了原本樂觀展望中的一些薄弱環節。</p>
</div><p>DocuSign’s annual recurring revenue guidance, for example, remained unchanged at 8.5% growth, which many had viewed as the most important metric heading into the report. There was also a sense that visibility into the company’s IAM growth trajectory remains limited. These reasons alone were enough for Bank of America to maintain its Underperform rating.</p>
<div class="lb-trans"><p>例如，DocuSign 的年度經常性收入指引保持不變，增長率為 8.5%，許多人認為這是進入報告前最重要的指標。此外，市場對公司 IAM 增長軌跡的可見性仍然有限。這些原因足以讓美國銀行維持其表現不佳的評級。</p>
</div><p>Morgan Stanley struck a similarly cautious tone. While acknowledging strong execution and growing IAM adoption, it argued that the platform's economics remain difficult to evaluate. Still, it maintained its Equal-weight rating on the stock, and its price target of $69 suggests the market’s reaction has been way too negative. DocuSign shares were trading around $50 at the start of Friday’s session, which means bearish Morgan Stanley is targeting roughly 40% upside from here.</p>
<div class="lb-trans"><p>摩根士丹利也採取了類似的謹慎態度。儘管承認執行力強和 IAM 採用率上升，但它認為該平台的經濟性仍然難以評估。儘管如此，它維持了對該股票的平等權重評級，其目標價為 69 美元，表明市場的反應過於負面。DocuSign 的股票在週五交易開始時約為 50 美元，這意味着看空的摩根士丹利目標價大約有 40% 的上漲空間。</p>
</div><h2>Wall Street Wants Proof Before the Story Fully Plays Out</h2>
<div class="lb-trans"><h2>華爾街希望在故事完全展開之前看到證據</h2>
</div><p>The bullish argument is strong. Those willing to lean into the glass-half-full thesis see DocuSign as a company successfully transforming itself from a single-product provider into a broader agreement management platform. They see increasing customer adoption, growing product breadth, and the potential for AI-powered workflows to create entirely new monetization opportunities.</p>
<div class="lb-trans"><p>看漲的論點很強。願意傾向於樂觀論點的人認為 DocuSign 是一家成功將自己從單一產品提供商轉型為更廣泛的協議管理平台的公司。他們看到客户採用率的增加、產品範圍的擴大，以及 AI 驅動的工作流程創造全新貨幣化機會的潛力。</p>
</div><p>Importantly, management remains confident and has been repurchasing shares at record levels in recent months. These aren’t typically things you’d expect from a company going through an existential crisis.</p>
<div class="lb-trans"><p>重要的是，管理層依然充滿信心，並在最近幾個月以創紀錄的水平回購股票。這些通常不是你會期望在經歷生存危機的公司身上看到的事情。</p>
</div><p>The market's challenge is that these benefits have not yet fully materialized in projected growth rates, leaving investors frustrated. In a market where there are plenty of stocks ripping higher off the back of near-vertical growth rates, choosing to invest in DocuSign carries some pretty high opportunity costs.</p>
<div class="lb-trans"><p>市場的挑戰在於，這些好處尚未完全體現在預期的增長率中，令投資者感到沮喪。在一個許多股票因接近垂直的增長率而迅速上漲的市場中，選擇投資 DocuSign 的機會成本相當高。</p>
</div><h2>Why the Selloff Could Be an Opportunity</h2>
<div class="lb-trans"><h2>為什麼拋售可能是一個機會</h2>
</div><p>All that being said, there are more reasons to be bullish than bearish right now, especially when you consider how much the stock has sold off. The company is beating expectations, raising forward guidance, buying back its own shares and delivering promising results from its AI initiatives.</p>
<div class="lb-trans"><p>儘管如此，現在看漲的理由比看跌的理由更多，尤其是考慮到股票的拋售幅度。公司超出預期，提高了前瞻性指引，回購了自己的股票，並在其 AI 舉措中交出了令人鼓舞的結果。</p>
</div><h3>Docusign Inc. (DOCU) Price Chart for Monday, June, 8, 2026</h3>
<div class="lb-trans"><h3>Docusign Inc. (DOCU) 2026 年 6 月 8 日的價格圖表</h3>
</div><p>It might not be doing all of this at the pace investors might expect, or at a pace similar to other software stocks, but it’s still solid forward momentum. Against that backdrop, DocuSign shares continue to trade close to multi-year lows, which means the risk-reward profile is particularly attractive right now.</p>
<div class="lb-trans"><p>儘管它可能沒有以投資者期望的速度，或與其他軟件股票相似的速度進行所有這些操作，但它仍然保持着穩健的向前勢頭。在這種背景下，DocuSign 的股票仍然接近多年來的低點，這意味着當前的風險回報特徵特別有吸引力。</p>
</div><h2>Should You Invest $1,000 in Docusign Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Docusign 嗎？</h2>
</div><p>Before you consider Docusign, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Docusign 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Docusign 並不在名單上。</p>
</div><p>While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Docusign 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong

Market Beat

Docusign

HubSpot

美國銀行

摩根士丹利

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Docusign：再一次超出預期，再一次遭遇拋售——分析師為何判斷失誤